Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?

G, Romano; L, Patti; F, Innelli; Marino L, Di; G, Annuzzi; M, Iavicoli; GA, Coronel; G, Riccardi; AA, Rivellese

doi:10.2337/diacare.46.10.1601

Public

Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?

Shared by NobleBlocks on Oct 1, 1997 • 12:00 AM UTC

Authors:

Romano G

Patti L

Innelli F

Abstract

This study evaluates the effects of insulin versus glibenclamide on lipoprotein metabolism at comparable levels of blood glucose control, in particular on the concentration and distribution of VLDL subfractions and lipolytic enzyme activities in nine NIDDM men (aged 56 +/- 3 years, BMI 26.5 +/- 0.9 ...

Discussions